Chemoradiation therapy (CRT) for head and neck cancer is overused at some centers in patients with early-stage laryngeal cancer, and more care should be taken not to overtreat patients with therapy that can have toxic effects, said invited lecturer Jonas Johnson, MD, at the Annual Meeting of the Triological Society, held here on April 29 as part of the Combined Otolaryngology Spring Meetings.
The idea of reusing single-use devices may bring to mind the recent news of a Las Vegas urologist who was investigated in March for supposedly resuing single-use devices. As the Las Vegas Review-Journal reports, Dr. Michael Kaplan is accussed of reusing, but not not decontaminating, endocavity needle guides. While Dr. Kaplan’s specific case may be unique, the idea of reprocessing single-use devices is not.
Quantitative real-time polymerase chain reaction (Q-PCR) can be a valuable tool in the operating room to determine whether head and neck cancer patients should go on to elective neck dissection, researchers said here on April 29 at the Annual Meeting of the Triological Society, held as part of the Combined Otolaryngology Spring Meetings.
When performing certain procedures, many otolaryngologists use succinylcholine, a neuromuscular blocking agent, to help them monitor the facial nerve.
Regarding the article, “Otolaryngologist Pioneers New Practice Model: Dr. Russell heralds hospitalist role as others ponder the concept’s staying power”…
For decades, otolaryngologists have been frustrated by the refusal of some patients with hearing loss to use hearing aids. Statistics on noncompliance vary, but there is general agreement that only about 20 percent to 25 percent of Americans with treatable hearing loss use hearing aids. The problem seems to be more acute for people with mild hearing loss: A consumer survey conducted by the nonprofit Better Hearing Institute in 2009 found that fewer than 10 percent of people with mild hearing loss use amplification and that even among people with moderate-to-severe hearing loss, only four in 10 use amplification.
An increasing number of physicians are venturing onto the web, and, in particular, into social media. Recently, my client Dr. M was advised by a consultant to update his practice’s website, create a Facebook page for his practice and join Twitter. The marketing consultant cautioned Dr. M that there are legal concerns for health care providers associated with the Internet and social media. While social media can be a beneficial marketing tool, it is important for physicians to have in place a specific media policy that addresses the proper ways to use this outreach both in and outside the workplace.
A little over a year ago, I wrote an op-ed piece for ENT Today titled, “The Gender Gap in Otolaryngology: How do we make it disappear?” (February 2010). I challenged our specialty to find innovative and inclusive ways to tap into the extraordinary pool of talent found in our women otolaryngologists. And thanks to some extraordinarily enlightened leadership, we did it! Way beyond all hopes and expectations, the men and women of our specialty have paved the way for meaningful and fruitful change.
If you think your patients are finding your otolaryngology practice by looking in the Yellow Pages, think again. Increasingly, patients are deciding which physician to call by visiting the web and reading feedback on sites like vitals.com, healthgrades.com, lifescript.com and drscore.com.
At the Triological Society’s Annual Meeting in April, Robert H. Ossoff, DMD, MD, Maness Professor of Laryngology and Voice and assistant vice-chancellor for compliance and corporate integrity at Vanderbilt University Medical Center in Nashville, will assume the presidency of the society. Dr. Ossoff will be filling the role currently held by Gerald Berke, MD, chief of head and neck surgery at the University of California, Los Angeles.